Hypothesis

9 Matching Annotations

Feb 2026
www.sciencedirect.com www.sciencedirect.com

comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders

1
1. scibot 24 Feb 2026
  
  in Public
  
  RRID:AB_2565964
  
  DOI: 10.1016/j.stem.2026.01.010
  
  Resource: (BioLegend Cat# 362546, RRID:AB_2565964)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2565964
  
  What is this?
  
  RRID:AB_2565964
Visit annotations in context

Tags

RRID:AB_2565964

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1934590926000330
Aug 2024
www.sciencedirect.com www.sciencedirect.com

Isolation, expansion, and adoptive transfer of human ILC2s for the treatment of mice bearing liquid and solid tumors

1
1. scibot 19 Aug 2024
  
  in Public
  
  AB_2565964
  
  DOI: 10.1016/j.xpro.2024.103096
  
  Resource: (BioLegend Cat# 362546, RRID:AB_2565964)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2565964
  
  What is this?
  
  RRID:AB_2565964
Visit annotations in context

Tags

RRID:AB_2565964

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666166724002612
Apr 2024
www.sciencedirect.com www.sciencedirect.com

Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer

1
1. scibot 25 Apr 2024
  
  in Public
  
  RRID:AB_2565964
  
  DOI: 10.1016/j.stem.2024.03.018
  
  Resource: (BioLegend Cat# 362546, RRID:AB_2565964)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2565964
  
  What is this?
  
  RRID:AB_2565964
Visit annotations in context

Tags

RRID:AB_2565964

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1934590924001243
Jan 2024
www.sciencedirect.com www.sciencedirect.com

Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death

1
1. scibot 11 Jan 2024
  
  in Public
  
  RRID:AB_2565964
  
  DOI: 10.1016/j.cell.2023.12.015
  
  Resource: (BioLegend Cat# 362546, RRID:AB_2565964)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2565964
  
  What is this?
  
  RRID:AB_2565964
Visit annotations in context

Tags

RRID:AB_2565964

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867423013478
Nov 2022
www.sciencedirect.com www.sciencedirect.com

Protocol for evaluating antitumor activity of KIR3DL3 blockade in an NK cell-based xenogeneic lung tumor model

1
1. scibot 05 Nov 2022
  
  in Public
  
  RRID:AB_2565964
  
  DOI: 10.1016/j.xpro.2022.101818
  
  Resource: (BioLegend Cat# 362546, RRID:AB_2565964)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2565964
  
  What is this?
  
  RRID:AB_2565964
Visit annotations in context

Tags

RRID:AB_2565964

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666166722006980
Apr 2021
www.sciencedirect.com www.sciencedirect.com

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

1
1. scibot 24 Apr 2021
  
  in Public
  
  RRID:AB_2565964
  
  DOI: 10.1016/j.cell.2020.08.053
  
  Resource: (BioLegend Cat# 362546, RRID:AB_2565964)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2565964
  
  What is this?
  
  RRID:AB_2565964
Visit annotations in context

Tags

RRID:AB_2565964

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867420311417
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Alterations in T and B cell function persist in convalescent COVID-19 patients

1
1. scibot 17 Apr 2021
  
  in Public
  
  RRID:AB_2565964
  
  DOI: 10.1016/j.medj.2021.03.013
  
  Resource: (BioLegend Cat# 362546, RRID:AB_2565964)
  
  Curator: @evieth
  
  SciCrunch record: RRID:AB_2565964
  
  What is this?
  
  RRIDCUR:Validated RRID:AB_2565964
Visit annotations in context

Tags

RRID:AB_2565964

RRIDCUR:Validated

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8011689/
Feb 2021
www.sciencedirect.com www.sciencedirect.com

Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1

1
1. scibot 27 Feb 2021
  
  in Public
  
  RRID:AB_2565964
  
  DOI: 10.1016/j.xcrm.2020.100141
  
  Resource: (BioLegend Cat# 362546, RRID:AB_2565964)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_2565964
  
  What is this?
  
  RRID:AB_2565964
Visit annotations in context

Tags

RRID:AB_2565964

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379120301853
Nov 2020
www.sciencedirect.com www.sciencedirect.com

Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1

1
1. scibot 24 Nov 2020
  
  in Public
  
  RRID:AB_2565964
  
  DOI: 10.1016/j.xcrm.2020.100141
  
  Resource: (BioLegend Cat# 362546, RRID:AB_2565964)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:AB_2565964
  
  What is this?
  
  RRIDCUR:Validated RRID:AB_2565964
Visit annotations in context

Tags

RRID:AB_2565964

RRIDCUR:Validated

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379120301853